- Home
- URGN vs WOOF Comparison
URGN vs WOOF Comparison
Compare URGN & WOOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | URGN | WOOF |
|---|---|---|
| Founded | 2004 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 922.1M | 871.9M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | URGN | WOOF |
|---|---|---|
| Price | $19.99 | $2.59 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 12 |
| Target Price | ★ $29.50 | $3.92 |
| AVG Volume (30 Days) | 728.3K | ★ 2.0M |
| Earning Date | 03-09-2026 | 11-25-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $96,516,000.00 | ★ $5,998,469,000.00 |
| Revenue This Year | $26.47 | N/A |
| Revenue Next Year | $110.65 | $0.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 8.00 | N/A |
| 52 Week Low | $3.42 | $2.28 |
| 52 Week High | $30.00 | $4.51 |
Technical Indicators
Market Signals| Indicator | URGN | WOOF |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 32.71 |
| Support Level | $18.97 | $2.65 |
| Resistance Level | $22.07 | $3.02 |
| Average True Range (ATR) | 1.31 | 0.11 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 49.24 | 9.09 |
Price Performance
Historical ComparisonAbout URGN UroGen Pharma Ltd.
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.
About WOOF Petco Health and Wellness Company Inc.
Petco Health and Wellness Co Inc is a pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners with pet care centers in approximately 50 states, the District of Columbia and Puerto Rico. The Company also offers an expanded range of consumables, supplies, and services through its website and mobile app.